Cheryl R. Blanchard
2020 - Anika Therapeutics
In 2020, Cheryl R. Blanchard earned a total compensation of $10M as President and Chief Executive Officer at Anika Therapeutics.
Compensation breakdown
| Bonus | $458,510 |
|---|---|
| Option Awards | $3,659,450 |
| Salary | $548,077 |
| Stock Awards | $5,335,439 |
| Other | $27,958 |
| Total | $10,029,434 |
Blanchard received $5.3M in stock awards, accounting for 53% of the total pay in 2020.
Blanchard also received $458.5K in bonus, $3.7M in option awards, $548.1K in salary and $28K in other compensation.
Rankings
In 2020, Cheryl R. Blanchard's compensation ranked 832nd out of 13,090 executives tracked by ExecPay. In other words, Blanchard earned more than 93.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 832 out of 13,090 | 94th |
Division Manufacturing | 294 out of 5,621 | 95th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 35 out of 799 | 96th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 15 out of 495 | 97th |
Industry Surgical and Medical Instruments and Apparatus | 9 out of 313 | 97th |
Source: SEC filing on April 30, 2021.
Blanchard's colleagues
We found six more compensation records of executives who worked with Cheryl R. Blanchard at Anika Therapeutics in 2020.
2020
Michael Levitz
Anika Therapeutics
Chief Financial Officer
2020
David Colleran
Anika Therapeutics
General Counsel
2020
Sylvia Cheung
Anika Therapeutics
Chief Financial Officer
2020
Thomas Finnerty
Anika Therapeutics
EVP, Human Resources
2020
James Loerop
Anika Therapeutics
EVP, Business Development and Strategic Planning
2020
Joseph Darling
Anika Therapeutics